Table:
begin	end	state
1	11	cytoplasmic
12	40	transmembrane
41	47	non-cytoplasmic
48	71	transmembrane
72	82	cytoplasmic
83	104	transmembrane
105	115	non-cytoplasmic
116	138	transmembrane
139	157	cytoplasmic
158	177	transmembrane
178	183	non-cytoplasmic
184	203	transmembrane
204	233	cytoplasmic
234	258	transmembrane
259	272	non-cytoplasmic
273	293	transmembrane
294	299	cytoplasmic
300	319	transmembrane
320	329	non-cytoplasmic
330	353	transmembrane
354	364	cytoplasmic
365	388	transmembrane
389	393	non-cytoplasmic
394	415	transmembrane
416	434	cytoplasmic

Input:
>Pf6N2E2_1184
LDSQGRERRKLVLAVSVGAALEWFDFTLFAIFSLQIAAAFFPASDPLMSLLASYLALAVG
FVARPLGALLMGRYADRQGRKAALTLSIMLMGAGTLIIAVCPTYETIGWWAPLSVVVARI
LQGVAAGGEIGGALAYLVETAPADRRALFASSQQVAQAGSFLLCGLSASLLSSALTPAQL
DEWGWRVPYVFGLLVVVAGLKIRRSLEESEPLRRFLDNQDKHAMAGKGPSLRPYLPNLVM
GVLIVVLWTVATQLINFIPTYASMVLELPRNKAYLGLVLVGLITLLCPLTALLSDRIGRY
TVMLIGAVGVALCAYPGFVWLNNSPSLQTLIIFQCALAVLMVLYTGPAAAALAELFPVQV
RALGVSLAYALSVTLFGSATPALITLIYRQSGDALAAAHWLFAAACLSAIPLAWVSLSKY
RASATPALTAEHET

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server